Detalhe da pesquisa
1.
Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients.
Nephrol Dial Transplant
; 38(7): 1645-1654, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309473